New Connecticut Law Targets Drug and Device Manufacturers who Employ Sales Representatives for Additional Scrutiny
Eighth Circuit Finds “But-For” Causation Standard for AKS-Premised FCA Cases
CMS Issues Updated Open Payments FAQs
Future of discount safe harbor for prescription drugs remains uncertain
Plausibility Pleading in the Digital Age: Federal appellate courts take fresh look at Rule 8 in FCA context
FDA issues draft guidance regarding principles for selecting, developing, modifying, and adapting patient-reported outcome instruments for use in medical device evaluation
FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency
Subscribe: Subscribe via RSS
Firm/Org